×
Close
Sign Up
Login
Home
People
Photos
Videos
Topics
Bookmarks
Who viewed me
Events
Services
MDLA Events Platform
MDLA Events
MDLA Events Services & Pricing
Media Services & Pricing
User Tools
FAQ
Questions
User Notes
Feedback
Advertise with Us
Languages
English
中文
French
Português
Español
Arabic
Russian
About Us
Contact Us
×
Close
Search Filters
list
All Results
person
Activities
Search Results "#atopicdermatitis"
Activities
View More Results
Mary Grace N. Tamio
on December 16 2024 at 09:43 PM
Edited
public
Early life acute infections and risk for cow's milk protein allergy or atopic dermatitis at 6 months of age in high risk for allergy infants
#acuteinfection
#milkproteinallergy
#atopicdermatitis
#journals
#articles
More info | ⬇️
https://social.cn1699.cn/livenewss/news/1232503
Early life acute infections and risk for cow's milk protein allergy or atopic dermatitis at 6 months of age in high risk for allergy infants | CN1699 Social
The social Community for Global Healthcare Elites. Doctors, Medical Professionals & Pharmaceutical professionals. Medical Thesis Abstracts and...
0
0
0
0
0
0
0
comment
Comment
thumb_up
Like
share
Share
Mary Grace N. Tamio (Gra Sya)
on January 10 2024 at 08:14 PM
Edited
public
Efficacy and Safety of Dupilumab Treatment with Concomitant Topical Corticosteroids in Children Aged 6 Months to 5 Years with Severe Atopic Dermatitis
#dupilumabtreatment
#corticosteroids
#atopicdermatitis
#journals
#articles
More info | ⬇️
https://social.cn1699.cn/livenewss/news/1024304/Efficacy-and-Safety-of-Dupilumab-Treatment-with-Concomitant-Topical-Corticosteroids-in-Children-Aged-6-Months-to-5-Years-with-Severe-Atopic-Dermatitis
Efficacy and Safety of Dupilumab Treatment with Concomitant Topical Corticosteroids in Children Aged 6 Months to 5 Years with Severe Atopic Dermatitis | CN1699 Social
The social Community for Global Healthcare Elites. Doctors, Medical Professionals & Pharmaceutical professionals. Medical Thesis Abstracts and...
0
0
0
0
0
0
0
comment
Comment
thumb_up
Like
share
Share
Mary Grace N. Tamio (Gra Sya)
on November 05 2023 at 06:10 PM
Edited
public
Polysomnographic characteristics of sleep in adults with and without physician-diagnosed atopic dermatitis: results from the Study of Health in Pomerania
#polysomnography
#atopicdermatitis
#journals
#articles
More info | ⬇️
https://social.cn1699.cn/livenewss/news/979881/Polysomnographic-characteristics-of-sleep-in-adults-with-and-without-physician-diagnosed-atopic-dermatitis-results-from-the-Study-of-Health-in-Pomerania
Polysomnographic characteristics of sleep in adults with and without physician-diagnosed atopic dermatitis: results from the Study of Health in Pomerania | CN1699 Social
The social Community for Global Healthcare Elites. Doctors, Medical Professionals & Pharmaceutical professionals. Medical Thesis Abstracts and...
0
0
0
0
0
0
0
comment
Comment
thumb_up
Like
share
Share
Mary Grace N. Tamio (Gra Sya)
on August 02 2023 at 11:11 PM
Edited
public
Successful Treatment of Atopic Dermatitis with a Predominant Nipple Involvement by Abrocitinib During COVID-19 Pandemic: A Case Report
#atopicdermatitis
#abrocinitib
#covid19
#journals
#articles
More info | ⬇️
https://social.cn1699.cn/livenewss/news/922213/Successful-Treatment-of-Atopic-Dermatitis-with-a-Predominant-Nipple-Involvement-by-Abrocitinib-During-COVID-19-Pandemic-A-Case-Report
Successful Treatment of Atopic Dermatitis with a Predominant Nipple Involvement by Abrocitinib During COVID-19 Pandemic: A Case Report | CN1699 Social
The social Community for Global Healthcare Elites. Doctors, Medical Professionals & Pharmaceutical professionals. Medical Thesis Abstracts and...
0
0
0
0
0
0
0
comment
Comment
thumb_up
Like
share
Share
Mary Grace N. Tamio
on December 10 2022 at 06:33 PM
Edited
public
New treatment for moderate to severe atopic dermatitis shows promising long-term results
#atopicdermatitis
#dermatitis
More info | ⬇️
https://cn1699.com/news/new-treatment-moderate-severe-atopic-dermatitis-shows-promising-long-term-results
New treatment for moderate to severe atopic dermatitis shows promising long-term results | CN1699
Patients with moderate to severe atopic dermatitis who participated in a clinical trial of rocatinlimab—a novel, patient-tailored monoclonal...
0
0
0
0
0
0
0
comment
Comment
thumb_up
Like
share
Share
Modal title
×
Modal title
×
Share
Login
Global News and Health Forum
Join Now!
Member Login
Remember me
Forgot password?